Genenta Science S.p.A. (SAEN)
NASDAQ: SAEN · Real-Time Price · USD
0.7000
-0.2850 (-28.93%)
At close: Nov 4, 2026, 4:00 PM EST
0.6850
-0.0150 (-2.14%)
After-hours: Nov 4, 2026, 7:24 PM EST
Company Description
Genenta Science S.p.A. operates as a strategic consolidator that focuses on acquiring ownership of privately held companies operating in Italian national-security-regulated sectors.
Its activities and acquisition strategy covers aerospace, defense, national security, and biotechnology/biosecurity.
Genenta Science S.p.A. was incorporated in 2014 and is headquartered in Milan, Italy.
Genenta Science S.p.A.
| Country | Italy |
| Founded | 2014 |
| Employees | 9 |
| CEO | Pierluigi Paracchi |
Contact Details
Address: Via dell’Annunciata 31 Milan, Michigan 20121 Italy | |
| Phone | 39 02 29 00 10 55 |
| Website | genenta.com |
Stock Details
| Ticker Symbol | SAEN |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | EUR |
| CIK Code | 1838716 |
Key Executives
| Name | Position |
|---|---|
| Pierluigi Paracchi | Chief Executive Officer |
| Richard Slansky | Chief Financial Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Nov 2, 2026 | 6-K | Report of foreign issuer |
| Oct 22, 2026 | 6-K | Report of foreign issuer |
| Oct 21, 2026 | 6-K | Report of foreign issuer |
| Oct 13, 2026 | 6-K | Report of foreign issuer |
| Oct 7, 2026 | 6-K | Report of foreign issuer |
| Oct 2, 2026 | SCHEDULE 13D/A | Filing |
| Sep 11, 2026 | 6-K | Report of foreign issuer |
| Sep 2, 2026 | 6-K | Report of foreign issuer |
| Jul 31, 2026 | 6-K | Report of foreign issuer |
| Jul 14, 2026 | 6-K | Report of foreign issuer |